New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
08:20 EDTEVHCEnvision Healthcare announces waiver of certain IPO lock-up restrictions
Envision Healthcare Holdings announced that Goldman, Sachs & Co., Barclays Capital Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, book-running managers in the company’s initial public offering in August 2013, are waiving certain lock-up restrictions with respect to shares of the Company’s common stock held by certain investment funds sponsored by, or affiliated with, Clayton, Dubilier & Rice, LLC and certain officers and directors of the company. The waiver will take effect on February 5 and will permit the offer and sale of shares by the CD&R Affiliates and such officers and directors only in the company’s previously announced secondary offering of common stock. Subject to the terms of such waiver, the lock-up restrictions will otherwise remain in full force and effect.
News For EVHC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 23, 2015
08:07 EDTEVHCBofA/Merrill healthcare high yield analyst has analyst/industry conference call
Healthcare High Yield Analyst Bland provides an update on the current state of the bond markets and the ability of healthcare providers to utilize debt financing on an Analyst/Industry conference call to be held on March 24 at 10 am.
March 19, 2015
09:09 EDTEVHCTowers Watson sees 1.2M individuals choosing Towers in 2015
Subscribe for More Information
March 18, 2015
07:30 EDTEVHCDeutsche Bank to hold a conference
Subscribe for More Information
07:29 EDTEVHCEnvision Healthcare price target raised to $47 from $40 at Jefferies
Jefferies raised its price target for Envision Healthcare shares to $47 and elevated the stock to a Top 5 Pick saying the recent exit of the company's private equity sponsor has eliminated a long-standing overhang. The firm also believes acquisition opportunities in physician services could drive EBITDA and share upside between now and year-end. It keeps a Buy rating on Envision.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use